Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?
Fabrice Muscari, Charlotte Maulat
Topics & Concepts
MedicineHepatocellular carcinomaAlpha-fetoproteinBiomarkerAlpha (finance)Internal medicineGastroenterologyOncologySurgeryGeneticsBiologyPatient satisfactionConstruct validityHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentPancreatic and Hepatic Oncology Research